重症神経性食欲不振症患者における低体温症
Jeanie Meincke Egedal1,2, Tommy Tran1,2, Magnus Sjögren3
1Center for Eating Disorders, Odense University Hospital & Mental Health Services in the Region of Southern Denmark, Odense, Denmark.
Eating disorders
|January 28, 2026
まとめ
低体温症は、神経性食欲不振症(AN)の入院患者の10%以上に影響を与えており、しばしば見過ごされています。ほとんどの患者は治療により体温が正常化しますが、持続的な低体温症には標的を絞った介入が必要となる場合があります。
科学分野:
- 内科学
- 精神医学
- 臨床研究
背景:
- 低体温症は、神経性食欲不振症(AN)患者において一般的であるが、しばしば見過ごされる臨床的特徴です。
- 外部からの加熱は、ANにおける低体温症の支持療法として提案されています。
- 低体温症の頻度と相関因子を理解することは、効果的なAN管理のために不可欠です。
研究 の 目的:
- ANの専門的な入院患者集団における低体温症の頻度を決定すること。
- ANにおける低体温症の臨床的相関因子と影響を探求すること。
- AN患者における低体温症に関連する要因を特定すること。
主な方法:
- 日常的に収集された臨床データおよび生化学的データの後ろ向き研究。
- 低体温症を鼓膜温35.8℃未満と定義。
- 低体温症に関連する要因を特定するための多変量ロジスティック回帰分析。
主要な成果:
- 研究対象となった111人のAN患者の10.8%が低体温症を呈しました。
- 低体温症の患者のほとんどは、標準的なケアで入院中に正常体温になりました。
- 一部の患者では持続的な低体温症が観察されました。
結論:
- 低体温症は、相当な割合のAN入院患者における重要な臨床所見です。
- 標準的な医学的治療は、ほとんどのAN患者の低体温症を解決できます。
- 持続的な低体温症は、補助的な加温介入から恩恵を受ける可能性のある治療標的として、さらなる調査に値します。
関連する概念動画
Anorexia Nervosa
1.1K
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.1K
Bulimia Nervosa
749
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
749
Patient-centered Care
3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Geriatric Patients
232
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
232
Drug Dosing: Obese Patients
254
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254
Pharmacodynamics in Geriatric Patients: Effects of Age
202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202


